Get my own profile
Public access
View all25 articles
4 articles
available
not available
Based on funding mandates
Co-authors
- David P FairlieProfessor, University of QueenslandVerified email at imb.uq.edu.au
- David J CraikUniversity of QueenslandVerified email at imb.uq.edu.au
- Stanton F. McHardyAssociate Professor, Chemistry, UTSAVerified email at utsa.edu
- Scott LokeyUniversity of California Santa CruzVerified email at ucsc.edu
- Stephen MartinProfessor of Chemistry, University of Texas at AustinVerified email at mail.utexas.edu
- Huy N. HoangThe University of queenslandVerified email at uq.edu.au
- Timothy A HillSenior Reserch Officer, University of QueenslandVerified email at imb.uq.edu.au
- Matthew JacobsonUCSFVerified email at ucsf.edu
- Thomas ChappieVerified email at pfizer.com
- Christina I SchroederPeptide Therapeutics, Genentech, South San Francisco, CAVerified email at gene.com
- Jayvardhan PanditPfizerVerified email at pfizer.com
- Joshua SchwochertCo-founder and CSO, Unnatural ProductsVerified email at unnaturalproducts.com
- Daniel S. NielsenCenter for Evolutionary Chemical Biology, Department of Chemistry, University of Copenhagen, DenmarkVerified email at chem.ku.dk
- Dr Joakim E SwedbergThe University of QueenslandVerified email at imb.uq.edu.au
- Jamie H. D. CateVerified email at berkeley.edu
- Cameron PyeCEO, Unnatural Products IncVerified email at unnaturalproducts.com
- Michael P. DoyleUniv. Texas at San Antonio, Univ. Maryland, Univ. Arizona, Trinity Univ., Hope College, Univ. ofVerified email at utsa.edu
- Jennifer DoudnaProfessor of Molecular and Cell Biology and Chemistry, UC BerkeleyVerified email at berkeley.edu
- Manthena V. VarmaPharmacokinetics, dynamics and metabolismVerified email at pfizer.com
- Roland J. PietersUtrecht UniversityVerified email at uu.nl